SAF-Holland SE (LON: 0O4N)
London
· Delayed Price · Currency is GBP · Price in EUR 15.58
+0.14 (0.91%)
At close: Jan 22, 2025
SAF-Holland SE Revenue
SAF-Holland SE had revenue of 439.93M EUR in the quarter ending September 30, 2024, a decrease of -20.43%. This brings the company's revenue in the last twelve months to 1.97B, down -0.44% year-over-year. In the year 2023, SAF-Holland SE had annual revenue of 2.11B with 34.57% growth.
Revenue (ttm)
1.97B EUR
Revenue Growth
-0.44%
P/S Ratio
n/a
Revenue / Employee
332.32K EUR
Employees
5,927
Market Cap
600.41M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.11B | 541.08M | 34.57% |
| Dec 31, 2022 | 1.57B | 318.51M | 25.55% |
| Dec 31, 2021 | 1.25B | 287.06M | 29.92% |
| Dec 31, 2020 | 959.52M | -324.64M | -25.28% |
| Dec 31, 2019 | 1.28B | -16.40M | -1.26% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 221.41B |
| AstraZeneca | 38.20B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| BP p.l.c. | 144.69B |
| British American Tobacco p.l.c. | 26.18B |